Stryker Corporation $SYK Shares Bought by Swiss Life Asset Management Ltd

Swiss Life Asset Management Ltd raised its position in Stryker Corporation (NYSE:SYK) by 6.5% during the fourth quarter, HoldingsChannel.com reports. The firm owned 40,438 shares of the medical technology company’s stock after buying an additional 2,454 shares during the quarter. Swiss Life Asset Management Ltd’s holdings in Stryker were worth $14,213,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also modified their holdings of SYK. United Financial Planning Group LLC acquired a new stake in Stryker during the 3rd quarter worth approximately $27,000. CGC Financial Services LLC acquired a new position in Stryker during the fourth quarter valued at approximately $29,000. Strive Asset Management LLC purchased a new stake in Stryker during the third quarter worth approximately $30,000. ANTIPODES PARTNERS Ltd purchased a new stake in Stryker during the third quarter worth approximately $34,000. Finally, Copia Wealth Management increased its position in shares of Stryker by 181.6% in the third quarter. Copia Wealth Management now owns 107 shares of the medical technology company’s stock worth $40,000 after acquiring an additional 69 shares in the last quarter. 77.09% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently commented on SYK shares. Citigroup reduced their target price on shares of Stryker from $420.00 to $385.00 and set a “buy” rating on the stock in a report on Tuesday, April 7th. Needham & Company LLC lowered their price target on Stryker from $454.00 to $418.00 and set a “buy” rating for the company in a report on Friday, May 1st. Truist Financial restated a “hold” rating and set a $330.00 price objective (down from $380.00) on shares of Stryker in a research note on Monday, May 4th. UBS Group decreased their target price on Stryker from $400.00 to $380.00 and set a “neutral” rating for the company in a research report on Tuesday, March 17th. Finally, Wells Fargo & Company lowered their target price on Stryker from $456.00 to $418.00 and set an “overweight” rating for the company in a research note on Friday, May 1st. Sixteen equities research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company. Based on data from MarketBeat, Stryker presently has a consensus rating of “Moderate Buy” and an average price target of $395.48.

Stryker Stock Performance

Stryker stock opened at $282.85 on Tuesday. Stryker Corporation has a 12-month low of $281.00 and a 12-month high of $404.87. The company has a debt-to-equity ratio of 0.62, a current ratio of 2.11 and a quick ratio of 1.25. The company has a market capitalization of $108.33 billion, a price-to-earnings ratio of 32.74, a price-to-earnings-growth ratio of 1.80 and a beta of 0.80. The firm’s fifty day moving average price is $336.33 and its 200 day moving average price is $353.81.

Stryker (NYSE:SYK) last posted its quarterly earnings data on Thursday, April 30th. The medical technology company reported $2.60 earnings per share for the quarter, missing analysts’ consensus estimates of $2.98 by ($0.38). The firm had revenue of $6.02 billion during the quarter, compared to analysts’ expectations of $6.34 billion. Stryker had a net margin of 13.20% and a return on equity of 23.42%. The business’s quarterly revenue was up 2.6% on a year-over-year basis. During the same period in the previous year, the company earned $2.84 earnings per share. Stryker has set its FY 2026 guidance at 14.900-15.100 EPS. On average, research analysts forecast that Stryker Corporation will post 14.98 EPS for the current fiscal year.

Stryker Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Tuesday, June 30th will be issued a $0.88 dividend. The ex-dividend date of this dividend is Tuesday, June 30th. This represents a $3.52 dividend on an annualized basis and a yield of 1.2%. Stryker’s dividend payout ratio is currently 40.74%.

Stryker Profile

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.